Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (43): 6906-6912.doi: 10.3969/j.issn.2095-4344.2015.43.004

Previous Articles     Next Articles

Fabricating periodontal tissue engineering compound by gene modified gingival fibroblasts and acellular dermal matrix

Zhong Quan1, Li Yan-fen1, Yan Fu-hua2   

  1.  1Department of Periodontology, Affiliated Stomatological Hospital of Fujian Medical University, Fuzhou 35002, Fujian Province, China; 2Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, Jiangsu Province, China
  • Received:2015-07-18 Online:2015-10-15 Published:2015-10-15
  • Contact: Yan Fu-hua, Professor, Chief physician, Doctoral supervisor, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, Jiangsu Province, China
  • About author:Zhong Quan, M.D., Attending physician, Department of Periodontology, Affiliated Stomatological Hospital of Fujian Medical University, Fuzhou 35002, Fujian Province, China
  • Supported by:

    the Natural Science Foundation of Fujian province, No. 2012J05143; the National Natural Science Foundation of China, No. 30471892

Abstract:

BACKGROUND: Previous studies have found that human platelet-derived growth factor-B (PDGF-B)-transfected gingival fibroblasts are capable of rapid proliferation in vitro, which can secrete platelet-derived growth factor BB proteins.

OBJECTIVE: To explore the ability of PDGF-B-modified gingival fibroblasts in the acellular dermal matrix in vivo to form periodontal tissue engineering compound.
METHODS: Gingival fibroblasts from Beagle dogs transfected with or without PDGF-B gene were implanted into the acellular dermal matrix. Cell growth on the acellular dermal matrix was observed. PDGF-B gene-transfected gingival fibroblasts/acellular dermal matrix composite (experimental group), gingival fibrobalsts/acellular dermal matrix composite (control group) and acellular dermal matrix (blank group) were implanted subcutaneously into the nude mice, respectively. At 2, 4, 8 weeks after implantation, skin tissues were taken and observed histologically.
RESULTS AND CONCLUSION: PDGF-B gene-modified gingival fibroblasts and non-transfected gingival fibroblasts both grew and proliferated well in the acellular dermal matrix. At 8 weeks after implantation, in the blank group, the surrounding cells largely entered into the acellular dermal matrix, but produce less new collagen fibers, and the cells only grew on the original collagen scaffold; in the control group, a great amount of collagen fibers formed, the original collagen fibers in the acellular dermal matrix were replaced by newly formed collagens, but the original collagen structure was reserved; in the experimental group, a large scale of permineralization formed, and mineralized nodes were arranged along the original collagen scaffold. These findings indicate that PDGF-B gene modified gingival fibroblasts can acquire osteoplastic abilities in the acellular dermal matrix in vivo.
 

Key words: Platelet-Derived Growth Factor, Fibroblasts, Tissue Engineering